- Home
- SCOR vs NRSN Comparison
SCOR vs NRSN Comparison
Compare SCOR & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- NRSN
- Stock Information
- Founded
- SCOR 1999
- NRSN 2017
- Country
- SCOR United States
- NRSN Israel
- Employees
- SCOR N/A
- NRSN N/A
- Industry
- SCOR Business Services
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- NRSN Health Care
- Exchange
- SCOR Nasdaq
- NRSN Nasdaq
- Market Cap
- SCOR 27.2M
- NRSN 26.3M
- IPO Year
- SCOR 2007
- NRSN 2021
- Fundamental
- Price
- SCOR $7.88
- NRSN $1.31
- Analyst Decision
- SCOR Buy
- NRSN
- Analyst Count
- SCOR 3
- NRSN 0
- Target Price
- SCOR $12.83
- NRSN N/A
- AVG Volume (30 Days)
- SCOR 36.0K
- NRSN 181.1K
- Earning Date
- SCOR 11-12-2024
- NRSN 11-26-2024
- Dividend Yield
- SCOR N/A
- NRSN N/A
- EPS Growth
- SCOR N/A
- NRSN N/A
- EPS
- SCOR N/A
- NRSN N/A
- Revenue
- SCOR $356,212,000.00
- NRSN N/A
- Revenue This Year
- SCOR N/A
- NRSN N/A
- Revenue Next Year
- SCOR $3.32
- NRSN N/A
- P/E Ratio
- SCOR N/A
- NRSN N/A
- Revenue Growth
- SCOR N/A
- NRSN N/A
- 52 Week Low
- SCOR $4.89
- NRSN $0.47
- 52 Week High
- SCOR $20.97
- NRSN $2.33
- Technical
- Relative Strength Index (RSI)
- SCOR 69.09
- NRSN 61.44
- Support Level
- SCOR $5.16
- NRSN $1.23
- Resistance Level
- SCOR $6.22
- NRSN $1.34
- Average True Range (ATR)
- SCOR 0.75
- NRSN 0.10
- MACD
- SCOR 0.26
- NRSN 0.01
- Stochastic Oscillator
- SCOR 72.93
- NRSN 75.00
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.